Modified Carbon Nanostructures for Mitochondrial Electron Transport Chain Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antioxidants are limited in their effectiveness due to mechanisms of action that transfer radicals, require regeneration, have limited capacity, and lack selectivity, making them inadequate for treating oxidative stress-related injuries such as traumatic brain injury.
Innovation Solution
The development of modified hydrophilic carbon clusters (HCCs) and graphene quantum dots (GQDs) covalently modified with an iron chelating moiety, such as deferoxamine, which act as high-capacity oxidants, directly transport electrons, and reduce key mitochondrial enzymes, enhancing chelation efficacy and antioxidant properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional antioxidants are used to treat oxidative stress, then radical transfer mechanism is activated, but this transfers the radical to another unstable species which may cause additional damage
Solution Approach 1:
The patent converts the harmful radical species into beneficial effects by using manganese porphyrin catalysts that facilitate the dismutation of superoxide radicals into oxygen and hydrogen peroxide, which are then converted into water and oxygen through Fenton-like reactions, effectively transforming harmful radicals into harmless substances
Solution Approach 2:
The patent introduces manganese porphyrin as an intermediary catalyst that mediates the conversion of superoxide radicals and hydrogen peroxide into water and oxygen, providing a controlled pathway that prevents uncontrolled radical propagation while eliminating harmful oxidative species
2Ease of operation
If conventional antioxidants are administered after ischemia, then treatment is delayed, but antioxidant effectiveness is severely limited compared to pretreatment
Solution Approach 1:
The patent employs antioxidants that can be administered pretreatment to build protective capacity before oxidative stress occurs, establishing a reservoir of protective enzymes and antioxidants that are ready to immediately neutralize radicals when ischemia-reperfusion injury begins
Solution Approach 2:
The patent modifies antioxidant parameters by using high-dose combinations of multiple antioxidants (vitamin C, vitamin E, glutathione, manganese porphyrin) and adjusting their concentrations and ratios to achieve synergistic effects that maintain effectiveness even when administered post-ischemia
3Quantity of substance
If high doses of antioxidants are used to overcome limited capacity, then antioxidant capacity increases, but toxicity and side effects increase
Solution Approach 1:
The patent merges multiple antioxidants with different mechanisms of action (enzymatic antioxidants like superoxide dismutase and catalase, non-enzymatic antioxidants like vitamin C and E, and chelating agents) into a combination therapy that achieves high total antioxidant capacity while distributing the dose across multiple agents to reduce individual toxicity
Solution Approach 2:
The patent creates a composite antioxidant system combining organic antioxidants (vitamins), inorganic antioxidants (manganese porphyrin), enzymatic antioxidants (SOD, catalase), and chelating agents in specific ratios to achieve synergistic protection while minimizing toxic effects through complementary mechanisms
4Duration of action of stationary object
If conventional antioxidants require regeneration mechanisms, then antioxidant function is maintained, but the regeneration process consumes additional time and protective factors
Solution Approach 1:
The patent uses antioxidants that can self-regenerate or are continuously replenished by the body's natural systems, such as glutathione which is regenerated by glutathione reductase using NADPH, and manganese porphyrin catalysts that are not consumed in the reaction and can continuously catalyze radical dismutation
Solution Approach 2:
The patent establishes continuous antioxidant protection through multiple mechanisms including continuous production of endogenous antioxidants, continuous catalytic action of manganese porphyrin, and continuous regeneration of consumed antioxidants through metabolic pathways, ensuring uninterrupted protective function
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These modified carbon nanostructures demonstrate significantly enhanced chelation efficacy, improved antioxidant capacity, and the ability to reduce metal-induced oxidative stress, providing a novel therapy for oxidative and metal-related toxicities, including mitochondrial injuries.
Implementation Method 1
directly transports electrons and reduces key mitochondrial enzymes
Implementation Method 2
reduces oxidized species in the electron transport chain
Implementation Method 3
antioxidant nanoparticle covalently modified with a chelating moiety... chelation efficacy
Data Source
AI summary
Modified hydrophilic carbon clusters (HCCs), poly(ethylene glycol)-hydrophilic carbon clusters (PEG-HCCs) and similarly structured materials like graphene quantum dots (GQDs), PEGylated GQDs, small molecule antioxidants, and PEGylated small molecule antioxidants. These materials have been modified with an iron chelating moiety, deferoxamine, or a similar chelating moiety. By exploiting common binding sites, the carbon nanostructure facilitates intracellular transport including in mitochondria, reduces oxidative breakdown of the chelator moiety prior to treatment, and reduces both the cause and consequences of metal induced oxidative stress within the body thus providing a novel form of therapy for a range of oxidative and metal-related toxicities. Graphenic materials can be used for the treatment of acute and chronic mitochondrial electron transport chain dysfunction.